Bifodan and Aalborg University announce foundation of Probiotic Research Initiative

NewsGuard 100/100 Score

Bifodan A/S together with Aalborg University is pleased to announce the foundation of the Probiotic Research Initiative. Probiotic Research Initiative is a collaboration between Bifodan and the Biomedicine Group at Aalborg University to enhance the effectiveness of research across academia and industry related to the application of probiotics in health and disease.

The Biomedicine group at Aalborg University (AAU), Denmark is at the forefront of innovative research in understanding and addressing a variety of health-related issues, and the affiliation with University Hospital of Aalborg, allows this group of researchers to test basic research in the clinical setting in a very efficient manner. Probiotic Research Initiative will support both Bifodan and AAU in advancing and communicating scientific results related to probiotics in a very effective way.

Recently, at “Probiota 2019” in Copenhagen, Dr. Fereshteh Dardmeh (DVM, Ph.D.) presented her latest research with probiotics from Bifodan’s strain portfolio and says about the collaboration: ‘Bifodan strains are ready - they have been screened and developed and the cooperation between the Biomedicine group of Aalborg University with the research team at Bifodan has been very fruitful; Dr. Hiva Alipour (DVM, Ph.D.), another member of the probiotic initiative team also agrees and adds that “The collaboration between academia and the industry is very valuable and will help not only to significantly boost the scientific knowledge but to also further move probiotics from bench to bedside”.

Mr. Erik Brandsborg, Chief Scientific Officer at Bifodan A/S adds about the Probiotic Research Initiative:

The Probiotic Research Initiative at AAU, spearheaded by Fereshteh and Hiva, has shown unprecedented initiative and creativity in multidisciplinary research, from basic studies to clinical trials. This collaboration will strengthen our ongoing projects and provide a solid platform for further development of a wide range of application of probiotics. At Bifodan we are extremely pleased with this collaboration and proud to be partners in the Probiotic Research Initiative.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies